Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden

Karolinska University Hospital

Status: Unknown

Conditions: Idiopathic Pulmonary Fibrosis

Treatments: Other: Anti-fibrostic drugs

Study type: Observational

Funder types: Other

Identifiers

NCT04019080

180293

Details and patient eligibility

About

The objective of the current research project is, by using high quality Swedish registry data, to evaluate use, tolerance and effect of anti-fibrotic drugs in IPF-patients. Secondary study objectives are to determine the clinical profile, determinants of treatment adherence, long-term safety and to describe the patient journey from the first sign of disease to end of treatment.

Enrollment: 400 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All subjects included in the Swedish IPF-registry

Exclusion criteria

• None